Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 382.70
+7.65 (2.04%)
At close: Jul 7, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 38.38 billion as of July 7, 2026. Its market cap has increased by 3.26% in one year.
Market Cap
38.38B
Enterprise Value
41.66B
Revenue
9.44B
Ranking
n/a
PE Ratio
59.80
Stock Price
382.70
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 38.38B, an increase of 10,646.09%. That is a compound annual growth rate of 20.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 38.38B | 13.65% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 78.90B |
| FDC Limited | 70.54B |
| Bliss GVS Pharma | 53.55B |
| Novartis India | 36.27B |
| Unichem Laboratories | 33.32B |
| Morepen Laboratories | 32.32B |
| Kwality Pharmaceuticals | 27.77B |
| Hikal | 27.40B |